Leading research-driven pharmaceutical company Venus Remedies has dispatched the first batch of essential medicines worth USD 30,000 to Ukraine.
The company has also launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the noble cause.
Venus Remedies employees have responded enthusiastically to the appeal by coming forward with donations in large numbers, as per a company statement.
"With millions of people bearing the brunt of this devastating war, it is a humanitarian crisis that calls for the need to rise to the occasion and reach out to Ukrainians with life-saving essential supplies," said Akshansh Chaudhary, President, HR, Venus Remedies, who flagged off the relief aid from the company's premises in Panchkula on April 28.
Appreciating the gesture, the Ukrainian Embassy in a statement issued on May 2, said that Venus Remedies has "proved that it is not only a business-oriented company but also a responsible organisation which has always stood firm for such noble causes to help people around the globe".
"We thank Venus Remedies for providing aid to the people of Ukraine in their most difficult times and readily accepting our request to supply us life-saving drugs free of cost," it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)